PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism
The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer i...
Saved in:
Published in | Genes & genomics Vol. 40; no. 5; pp. 531 - 541 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Seoul
The Genetics Society of Korea
01.05.2018
Springer Nature B.V 한국유전학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer in Han (OR 1.34; 95% CI 1.17–1.69), Dai, (OR 1.33; 95% CI 1.12–1.70), and Bai (OR 1.14; 95% CI 1.08–1.57) people. T genotype was also observed to associate with invasive bladder cancer in all the three populations (Bai, OR 1.15, 95% CI 1.07–1.87; Dai, OR 1.17, 95% CI 1.05–2.23; Han, OR 1.22, 95% CI 1.10–2.09). PSCA m-RNA levels in T genotype bladder cancer tissues were significantly lower than those in C genotype. An enhancement of PSCA m-RNA level by over-expressing C or T genotype in bladder cancer cells both decreased the cell proliferation and migration, but not affected cell cycle. The increased cell apoptasis due to the over-expression of the two variants was observed. Those change of cell proliferation, migration, and apoptasis was more remarkable in over-expressed C genotype cells than those in over-expressed T genotype. T genotype was genetically high risk to the occurrence of bladder cancer. The decreased PSCA m-RNA levels were involved in the progress of bladder cancer. T allele takes more responsibility for PSCA m-RNA down-regulation to promote cell proliferation and migration and hinder cell apoptasis, thus leading to a higher risk. |
---|---|
AbstractList | The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer in Han (OR 1.34; 95% CI 1.17-1.69), Dai, (OR 1.33; 95% CI 1.12-1.70), and Bai (OR 1.14; 95% CI 1.08-1.57) people. T genotype was also observed to associate with invasive bladder cancer in all the three populations (Bai, OR 1.15, 95% CI 1.07-1.87; Dai, OR 1.17, 95% CI 1.05-2.23; Han, OR 1.22, 95% CI 1.10-2.09). PSCA m-RNA levels in T genotype bladder cancer tissues were significantly lower than those in C genotype. An enhancement of PSCA m-RNA level by over-expressing C or T genotype in bladder cancer cells both decreased the cell proliferation and migration, but not affected cell cycle. The increased cell apoptasis due to the over-expression of the two variants was observed. Those change of cell proliferation, migration, and apoptasis was more remarkable in over-expressed C genotype cells than those in over-expressed T genotype. T genotype was genetically high risk to the occurrence of bladder cancer. The decreased PSCA m-RNA levels were involved in the progress of bladder cancer. T allele takes more responsibility for PSCA m-RNA down-regulation to promote cell proliferation and migration and hinder cell apoptasis, thus leading to a higher risk.The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer in Han (OR 1.34; 95% CI 1.17-1.69), Dai, (OR 1.33; 95% CI 1.12-1.70), and Bai (OR 1.14; 95% CI 1.08-1.57) people. T genotype was also observed to associate with invasive bladder cancer in all the three populations (Bai, OR 1.15, 95% CI 1.07-1.87; Dai, OR 1.17, 95% CI 1.05-2.23; Han, OR 1.22, 95% CI 1.10-2.09). PSCA m-RNA levels in T genotype bladder cancer tissues were significantly lower than those in C genotype. An enhancement of PSCA m-RNA level by over-expressing C or T genotype in bladder cancer cells both decreased the cell proliferation and migration, but not affected cell cycle. The increased cell apoptasis due to the over-expression of the two variants was observed. Those change of cell proliferation, migration, and apoptasis was more remarkable in over-expressed C genotype cells than those in over-expressed T genotype. T genotype was genetically high risk to the occurrence of bladder cancer. The decreased PSCA m-RNA levels were involved in the progress of bladder cancer. T allele takes more responsibility for PSCA m-RNA down-regulation to promote cell proliferation and migration and hinder cell apoptasis, thus leading to a higher risk. The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer in Han (OR 1.34; 95% CI 1.17–1.69), Dai, (OR 1.33; 95% CI 1.12–1.70), and Bai (OR 1.14; 95% CI 1.08–1.57) people. T genotype was also observed to associate with invasive bladder cancer in all the three populations (Bai, OR 1.15, 95% CI 1.07–1.87; Dai, OR 1.17, 95% CI 1.05–2.23; Han, OR 1.22, 95% CI 1.10–2.09). PSCA m-RNA levels in T genotype bladder cancer tissues were significantly lower than those in C genotype. An enhancement of PSCA m-RNA level by over-expressing C or T genotype in bladder cancer cells both decreased the cell proliferation and migration, but not affected cell cycle. The increased cell apoptasis due to the over-expression of the two variants was observed. Those change of cell proliferation, migration, and apoptasis was more remarkable in over-expressed C genotype cells than those in over-expressed T genotype. T genotype was genetically high risk to the occurrence of bladder cancer. The decreased PSCA m-RNA levels were involved in the progress of bladder cancer. T allele takes more responsibility for PSCA m-RNA down-regulation to promote cell proliferation and migration and hinder cell apoptasis, thus leading to a higher risk. The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer in Han (OR 1.34; 95% CI 1.17–1.69), Dai, (OR 1.33; 95% CI 1.12–1.70), and Bai (OR 1.14; 95% CI 1.08–1.57) people. T genotype was also observed to associate with invasive bladder cancer in all the three populations (Bai, OR 1.15, 95% CI 1.07–1.87; Dai, OR 1.17, 95% CI 1.05–2.23; Han, OR 1.22, 95% CI 1.10–2.09). PSCA m-RNA levels in T genotype bladder cancer tissues were significantly lower than those in C genotype. An enhancement of PSCA m-RNA level by over-expressing C or T genotype in bladder cancer cells both decreased the cell proliferation and migration, but not affected cell cycle. The increased cell apoptasis due to the over-expression of the two variants was observed. Those change of cell proliferation, migration, and apoptasis was more remarkable in over-expressed C genotype cells than those in over-expressed T genotype. T genotype was genetically high risk to the occurrence of bladder cancer. The decreased PSCA m-RNA levels were involved in the progress of bladder cancer. T allele takes more responsibility for PSCA m-RNA down-regulation to promote cell proliferation and migration and hinder cell apoptasis, thus leading to a higher risk. The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han people in China. A potential mechanism of the T allele risk was also investigated. T allele increased the occurring risk of bladder cancer in Han (OR 1.34; 95% CI 1.17–1.69), Dai, (OR 1.33; 95% CI 1.12–1.70), and Bai (OR 1.14; 95% CI 1.08–1.57) people. T genotype was also observed to associate with invasive bladder cancer in all the three populations (Bai, OR 1.15, 95% CI 1.07–1.87; Dai, OR 1.17, 95% CI 1.05–2.23; Han, OR 1.22, 95% CI 1.10–2.09). PSCA m-RNA levels in T genotype bladder cancer tissues were significantly lower than those in C genotype. An enhancement of PSCA m-RNA level by over-expressing C or T genotype in bladder cancer cells both decreased the cell proliferation and migration, but not affected cell cycle. The increased cell apoptasis due to the over-expression of the two variants was observed. Those change of cell proliferation, migration, and apoptasis was more remarkable in over-expressed C genotype cells than those in over-expressed T genotype. T genotype was genetically high risk to the occurrence of bladder cancer. The decreased PSCA m-RNA levels were involved in the progress of bladder cancer. T allele takes more responsibility for PSCA m-RNA down-regulation to promote cell proliferation and migration and hinder cell apoptasis, thus leading to a higher risk. KCI Citation Count: 1 |
Author | Zhang, Zhuorui Shen, Jie Yang, Min Yang, Maolin Li, Wei Zhang, Ningnan Yu, Yanhong Yang, Junfeng |
Author_xml | – sequence: 1 givenname: Junfeng surname: Yang fullname: Yang, Junfeng organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 2 givenname: Wei surname: Li fullname: Li, Wei organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 3 givenname: Zhuorui surname: Zhang fullname: Zhang, Zhuorui organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 4 givenname: Jie surname: Shen fullname: Shen, Jie organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 5 givenname: Ningnan surname: Zhang fullname: Zhang, Ningnan organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 6 givenname: Min surname: Yang fullname: Yang, Min organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 7 givenname: Maolin surname: Yang fullname: Yang, Maolin organization: Department of Urology, First People’s Hospital of Yunnan Province – sequence: 8 givenname: Yanhong orcidid: 0000-0001-5690-3856 surname: Yu fullname: Yu, Yanhong email: yyhkm021@163.com organization: Department of Urology, First People’s Hospital of Yunnan Province |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29892961$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002347372$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqNkk1vEzEQhi1UREPpD-CCLHEBiQV_r30M4aOVKoEgnC2v127c7NrB3hxy5o_jdAtIlUBYsucwzzsz1ryPwUlM0QHwFKPXGKH2TcGUcNkgXK_gtFEPwIIgRRpFFD0BC6xa0Sje4lNwXsoNqodiJhh-BE6JkpUSeAF-fP66WuZCiGIISbiGuzQcxpR3m1BGGKLNzhRX4LRxMIeyhcnDbjB97zK0JtoaQoRvTXgF3x0fE3t4YSJ00yYGG6bDMb3ahGhuU6bWn1ycghng6OzGxNrmCXjozVDc-V08A98-vF-vLpqrTx8vV8urxjKqpsYgRJxHPfJcMKt8x1HHvUVGtF7yThgshSceMyx6xxjqhOOGIUmZcZKLjp6Bl3PdmL3e2qCTCbfxOult1ssv60vNCBWKiMq-mNldTt_3rkx6DMW6YTDRpX3RBImWtJRT9B8oZ7Ukkriiz--hN2mfY_10pSginEnZVurZHbXvRtfrXQ6jyQf9a2sVwDNgcyolO_8bwUgfzaFnc-hqDn00h1ZV097T1O2YKaQ4ZROGfyrJrCy1S7x2-c_Qfxf9BO66yT8 |
CitedBy_id | crossref_primary_10_1042_BSR20190342 crossref_primary_10_4239_wjd_v14_i12_1766 crossref_primary_10_1002_ijc_35046 crossref_primary_10_3390_diagnostics12081988 crossref_primary_10_1089_gtmb_2022_0067 crossref_primary_10_3389_or_2023_10603 |
Cites_doi | 10.1111/j.1464-410X.2006.06153.x 10.1186/1755-8166-7-1 10.1111/gtc.12228 10.1186/1465-6906-12-S1-P15 10.1016/j.canlet.2009.05.030 10.1073/pnas.1202189109 10.1038/ng.1109 10.1093/carcin/bgp323 10.1016/j.biocel.2011.01.002 10.1073/pnas.95.4.1735 10.1016/j.yexcr.2014.03.009 10.1002/jgm.1067 10.1158/0008-5472.CAN-05-2086 10.3892/ol.2014.2734 10.1097/FPC.0b013e328331b554 10.3390/ijms140612346 10.7314/APJCP.2014.15.20.8901 10.3322/caac.20107 10.1038/ng.421 10.1158/1078-0432.CCR-09-3169 10.1186/1471-2407-10-129 10.1016/j.urolonc.2011.02.004 10.1016/S0304-3835(01)00497-9 10.3390/genes7020009 10.1002/pros.20608 |
ContentType | Journal Article |
Copyright | The Genetics Society of Korea and Springer Science+Business Media B.V., part of Springer Nature 2018 Copyright Springer Science & Business Media 2018 |
Copyright_xml | – notice: The Genetics Society of Korea and Springer Science+Business Media B.V., part of Springer Nature 2018 – notice: Copyright Springer Science & Business Media 2018 |
DBID | AAYXX CITATION NPM 7X8 7S9 L.6 ACYCR |
DOI | 10.1007/s13258-018-0653-9 |
DatabaseName | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2092-9293 |
EndPage | 541 |
ExternalDocumentID | oai_kci_go_kr_ARTI_4236926 29892961 10_1007_s13258_018_0653_9 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81260375 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: National Natural Science Foundation of China grantid: 81260375 |
GroupedDBID | --- -EM 06D 0R~ 0VY 1N0 203 29~ 2KG 2VQ 30V 4.4 406 408 40D 5GY 67N 96X 9ZL AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH AAZMS ABAKF ABDZT ABECU ABFTV ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABXPI ACAOD ACDTI ACGFS ACHSB ACKNC ACMDZ ACMLO ACOKC ACPIV ACPRK ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETCA AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AOCGG AXYYD BGNMA CSCUP DDRTE DNIVK DPUIP DU5 EBLON EBS EIOEI EJD ESBYG FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HMJXF HRMNR HZB HZ~ I0C IAO IGS IHR IKXTQ IWAJR IXD J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O9- O9J PT4 R9I RLLFE ROL RSV S1Z S27 S3A S3B SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE T13 TSG U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 Z45 Z7U ZMTXR ZOVNA AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABRTQ NPM 7X8 7S9 L.6 AAFGU AAYFA ABFGW ABKAS ACBMV ACBRV ACBYP ACIGE ACIPQ ACTTH ACVWB ACWMK ACYCR ADMDM ADOXG AEFTE AESTI AEVTX AFNRJ AGGBP AIMYW AJDOV AKQUC Z83 |
ID | FETCH-LOGICAL-c439t-a002ef0d0f564c9fb50b5fc0a67f85b6a186f2f1416de440b6e5a40834ae856b3 |
IEDL.DBID | U2A |
ISSN | 1976-9571 2092-9293 |
IngestDate | Tue Nov 21 21:09:40 EST 2023 Fri Jul 11 11:26:37 EDT 2025 Fri Jul 11 03:22:26 EDT 2025 Fri Jul 25 11:16:59 EDT 2025 Mon Jul 21 05:55:54 EDT 2025 Thu Apr 24 22:56:17 EDT 2025 Tue Jul 01 03:53:16 EDT 2025 Fri Feb 21 02:38:47 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Cell proliferation PSCA rs2294008 (C/T) polymorphism Bladder cancer Over-expression Cell migration Cell apoptasis |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-a002ef0d0f564c9fb50b5fc0a67f85b6a186f2f1416de440b6e5a40834ae856b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5690-3856 |
PMID | 29892961 |
PQID | 2030254887 |
PQPubID | 2044424 |
PageCount | 11 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_4236926 proquest_miscellaneous_2067273530 proquest_miscellaneous_2054926081 proquest_journals_2030254887 pubmed_primary_29892961 crossref_primary_10_1007_s13258_018_0653_9 crossref_citationtrail_10_1007_s13258_018_0653_9 springer_journals_10_1007_s13258_018_0653_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-05-01 |
PublicationDateYYYYMMDD | 2018-05-01 |
PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Seoul |
PublicationPlace_xml | – name: Seoul – name: Korea (South) – name: Heidelberg |
PublicationTitle | Genes & genomics |
PublicationTitleAbbrev | Genes Genom |
PublicationTitleAlternate | Genes Genomics |
PublicationYear | 2018 |
Publisher | The Genetics Society of Korea Springer Nature B.V 한국유전학회 |
Publisher_xml | – name: The Genetics Society of Korea – name: Springer Nature B.V – name: 한국유전학회 |
References | Fu, Kohaar, Rothman, Earl, Figueroa, Ye (CR5) 2012; 109 Tanikawa, Urabe, Matsuo, Kubo, Takahashi, Ito (CR22) 2012; 44 Qiang, Wang, Shi, Liu, Chen, Wan (CR17) 2011; 43 Dudek, Grotenhuis, Vermeulen, Kiemeney, Verhaegh (CR3) 2013; 14 Liu, Yang (CR12) 2011; 33 Elsamman, Fukumori, Kasai, Nakatsuji, Nishitani, Toida (CR4) 2006; 97 Wu, Ye, Kiemeney, Sulem, Rafnar, Matullo (CR24) 2009; 41 Marra, Uva, Viti, Simonelli, Dogliotti, De Rinaldis (CR14) 2010; 10 Zheng, Chen, Tian, Hao (CR29) 2015; 9 Morgenroth, Cartellieri, Schmitz, Günes, Weigle, Bachmann (CR15) 2007; 67 Mumy, Kohaar, Porte-Gill, Tang, Fu, Prokunina-Olsson (CR16) 2011; 12 Zhao, Ma, Zeng (CR28) 2013; 31 Golka, Hermes, Selinski, Blaszkewicz, Bolt, Roth (CR6) 2009; 19 Bahrenberg, Brauers, Joost, Jakse (CR1) 2001; 168 Jemal, Bray, Center, Ferlay, Ward, Forman (CR9) 2011; 61 Song, Wang, Zhao, Yao, Liu, Ma (CR21) 2014; 324 Lee, Song, Kim, Kweon, Yun, Choi (CR10) 2014; 15 Reiter, Gu, Watabe, Thomas, Szigeti, Davis (CR18) 1998; 95 Wang, Tang, Wang, Yuan, Zhang (CR23) 2010; 31 Gu, Yamashiro, Kono, Reiter (CR7) 2005; 65 Zhang, Wu, Qiu, Dong, Zhu, Lee (CR27) 2016; 37 Liu, Jiang, Wang, Yu, Shi, Zhou (CR13) 2009; 286 Li, Yu, Cheng, Huang, Weng (CR11) 2015; 8 Saeki, Ono, Yanagihara, Aoyagi, Sasaki, Sakamoto (CR20) 2016; 20 Xu, Wang, Fu, Meng, Lang (CR25) 2015; 8 Zhang, Yu, Zhao, Fu, Yi, Liu (CR26) 2007; 9 Saeki, Gu, Yoshida, Wu (CR19) 2010; 16 Jaiswal, Singh, Kapoor, Mittal (CR8) 2014; 7 Chandra, Kim, Gupta, Mittal, Rai (CR2) 2016; 7 E Marra (653_CR14) 2010; 10 AM Dudek (653_CR3) 2013; 14 X Zhang (653_CR26) 2007; 9 Z Zhao (653_CR28) 2013; 31 V Chandra (653_CR2) 2016; 7 RE Reiter (653_CR18) 1998; 95 X Wu (653_CR24) 2009; 41 N Saeki (653_CR19) 2010; 16 ZA Liu (653_CR12) 2011; 33 M Li (653_CR11) 2015; 8 K Zheng (653_CR29) 2015; 9 N Saeki (653_CR20) 2016; 20 Z Gu (653_CR7) 2005; 65 S Wang (653_CR23) 2010; 31 X Xu (653_CR25) 2015; 8 X Liu (653_CR13) 2009; 286 R Qiang (653_CR17) 2011; 43 PK Jaiswal (653_CR8) 2014; 7 A Jemal (653_CR9) 2011; 61 JH Lee (653_CR10) 2014; 15 A Morgenroth (653_CR15) 2007; 67 A Mumy (653_CR16) 2011; 12 E Elsamman (653_CR4) 2006; 97 C Tanikawa (653_CR22) 2012; 44 YP Fu (653_CR5) 2012; 109 Y Song (653_CR21) 2014; 324 K Golka (653_CR6) 2009; 19 LY Zhang (653_CR27) 2016; 37 G Bahrenberg (653_CR1) 2001; 168 24657544 - Exp Cell Res. 2014 May 15;324(1):54-64 20501618 - Clin Cancer Res. 2010 Jul 15;16(14):3533-8 26785734 - Carcinogenesis. 2016 Mar;37(3):320-332 21296855 - CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 16230414 - Cancer Res. 2005 Oct 15;65(20):9495-500 26891331 - Genes (Basel). 2016 Feb 16;7(2):null 16686711 - BJU Int. 2006 Jun;97(6):1202-7 17595048 - J Gene Med. 2007 Aug;9(8):715-26 19801959 - Pharmacogenet Genomics. 2009 Nov;19(11):903-6 21429770 - Urol Oncol. 2013 Apr;31(3):343-51 20374648 - BMC Cancer. 2010 Apr 07;10:129 26550251 - Int J Clin Exp Med. 2015 Aug 15;8(8):13259-66 22387998 - Nat Genet. 2012 Mar 04;44(4):430-4, S1-2 22416122 - Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4974-9 17492652 - Prostate. 2007 Jul 1;67(10):1121-31 20083643 - Carcinogenesis. 2010 Apr;31(4):621-4 9465086 - Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1735-40 25727947 - Genes Cells. 2015 May;20(5):382-91 25624885 - Oncol Lett. 2015 Feb;9(2):557-562 19648920 - Nat Genet. 2009 Sep;41(9):991-5 25374226 - Asian Pac J Cancer Prev. 2014;15(20):8901-4 26722457 - Int J Clin Exp Pathol. 2015 Oct 01;8(10 ):12678-87 11368875 - Cancer Lett. 2001 Jul 10;168(1):37-43 19540661 - Cancer Lett. 2009 Dec 28;286(2):217-22 21216304 - Int J Biochem Cell Biol. 2011 Apr;43(4):632-41 23752272 - Int J Mol Sci. 2013 Jun 10;14(6):12346-66 |
References_xml | – volume: 97 start-page: 1202 year: 2006 end-page: 1207 ident: CR4 article-title: Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder publication-title: BJU Int doi: 10.1111/j.1464-410X.2006.06153.x – volume: 7 start-page: 1 year: 2014 end-page: 1 ident: CR8 article-title: Genetic variation in PSCA gene and bladder cancer susceptibility in North Indian population publication-title: Mol Cytogenet doi: 10.1186/1755-8166-7-1 – volume: 20 start-page: 382 year: 2016 end-page: 391 ident: CR20 article-title: Rs2294008T, a risk allele for gastric and gallbladder cancers, suppresses the PSCA promoter by recruiting the transcription factor YY1 publication-title: Gene Cell doi: 10.1111/gtc.12228 – volume: 12 start-page: 1 year: 2011 end-page: 25 ident: CR16 article-title: Prostate stem cell antigen (PSCA) and risk of bladder cancer: linking genotypes to functional mechanisms publication-title: Genome Biol doi: 10.1186/1465-6906-12-S1-P15 – volume: 286 start-page: 217 year: 2009 end-page: 222 ident: CR13 article-title: MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines publication-title: Cancer Lett doi: 10.1016/j.canlet.2009.05.030 – volume: 109 start-page: 4974 year: 2012 end-page: 4979 ident: CR5 article-title: Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1202189109 – volume: 44 start-page: 430 year: 2012 end-page: 434 ident: CR22 article-title: A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population publication-title: Nat Genet doi: 10.1038/ng.1109 – volume: 31 start-page: 621 year: 2010 end-page: 624 ident: CR23 article-title: Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population publication-title: Carcinogenesis doi: 10.1093/carcin/bgp323 – volume: 43 start-page: 632 year: 2011 end-page: 641 ident: CR17 article-title: Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2011.01.002 – volume: 95 start-page: 1735 year: 1998 end-page: 1740 ident: CR18 article-title: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.4.1735 – volume: 324 start-page: 54 year: 2014 end-page: 64 ident: CR21 article-title: MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2014.03.009 – volume: 9 start-page: 715 year: 2007 end-page: 726 ident: CR26 article-title: Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+, T-cell response and inhibits the PSCA , tumors growth in mice publication-title: J Gene Med doi: 10.1002/jgm.1067 – volume: 65 start-page: 9495 year: 2005 end-page: 9500 ident: CR7 article-title: Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2086 – volume: 9 start-page: 557 year: 2015 end-page: 562 ident: CR29 article-title: Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder publication-title: Oncol Lett doi: 10.3892/ol.2014.2734 – volume: 19 start-page: 903 year: 2009 end-page: 908 ident: CR6 article-title: Susceptibility to urinary bladder cancer: relevance of rs9642880 [T], GSTM1 and occupational exposure publication-title: Pharmacogent Genom doi: 10.1097/FPC.0b013e328331b554 – volume: 14 start-page: 12346 year: 2013 end-page: 12366 ident: CR3 article-title: Urinary bladder cancer susceptibility markers. what do we know about functional mechanisms? publication-title: Int J Mol Sci doi: 10.3390/ijms140612346 – volume: 15 start-page: 8901 year: 2014 end-page: 8904 ident: CR10 article-title: Genetic variation in PSCA is associated with bladder cancer susceptibility in a Korean population publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2014.15.20.8901 – volume: 61 start-page: 69 year: 2011 end-page: 90 ident: CR9 article-title: Global cancer statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 41 start-page: 991 year: 2009 end-page: 995 ident: CR24 article-title: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer publication-title: Nat Genet doi: 10.1038/ng.421 – volume: 16 start-page: 3533 year: 2010 end-page: 3538 ident: CR19 article-title: Prostate stem cell antigen: a Jekyll and Hyde molecule? publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-3169 – volume: 8 start-page: 12678 year: 2015 end-page: 12687 ident: CR25 article-title: Differentially expressed genes and microRNAs in bladder carcinoma cell line 5637 and T24 detected by RNA sequencing publication-title: Int J Clin Exp Pathol – volume: 10 start-page: 129 year: 2010 ident: CR14 article-title: Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways publication-title: BMC Cancer doi: 10.1186/1471-2407-10-129 – volume: 31 start-page: 343 year: 2013 end-page: 351 ident: CR28 article-title: Small interference Rna-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer Pc-3M cells publication-title: Urol Oncol-Semin Ori doi: 10.1016/j.urolonc.2011.02.004 – volume: 168 start-page: 37 year: 2001 end-page: 43 ident: CR1 article-title: PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112 publication-title: Cancer Lett doi: 10.1016/S0304-3835(01)00497-9 – volume: 7 start-page: 1065 year: 2016 end-page: 1075 ident: CR2 article-title: Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) gene polymorphism in modulating cancer risk in Asian population publication-title: Genes doi: 10.3390/genes7020009 – volume: 33 start-page: 42 year: 2011 end-page: 44 ident: CR12 article-title: New perspective of the research of the primitive religion of the Dai people publication-title: J Chuxiong Teach College – volume: 8 start-page: 13259 year: 2015 end-page: 13266 ident: CR11 article-title: Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer publication-title: Int J Cli Exp Med – volume: 37 start-page: 449 year: 2016 end-page: 454 ident: CR27 article-title: PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma publication-title: Carcinogenesis – volume: 67 start-page: 1121 year: 2007 end-page: 1131 ident: CR15 article-title: Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells publication-title: Prostate doi: 10.1002/pros.20608 – volume: 8 start-page: 13259 year: 2015 ident: 653_CR11 publication-title: Int J Cli Exp Med – volume: 33 start-page: 42 year: 2011 ident: 653_CR12 publication-title: J Chuxiong Teach College – volume: 8 start-page: 12678 year: 2015 ident: 653_CR25 publication-title: Int J Clin Exp Pathol – volume: 286 start-page: 217 year: 2009 ident: 653_CR13 publication-title: Cancer Lett doi: 10.1016/j.canlet.2009.05.030 – volume: 12 start-page: 1 year: 2011 ident: 653_CR16 publication-title: Genome Biol doi: 10.1186/1465-6906-12-S1-P15 – volume: 97 start-page: 1202 year: 2006 ident: 653_CR4 publication-title: BJU Int doi: 10.1111/j.1464-410X.2006.06153.x – volume: 31 start-page: 621 year: 2010 ident: 653_CR23 publication-title: Carcinogenesis doi: 10.1093/carcin/bgp323 – volume: 9 start-page: 715 year: 2007 ident: 653_CR26 publication-title: J Gene Med doi: 10.1002/jgm.1067 – volume: 95 start-page: 1735 year: 1998 ident: 653_CR18 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.4.1735 – volume: 44 start-page: 430 year: 2012 ident: 653_CR22 publication-title: Nat Genet doi: 10.1038/ng.1109 – volume: 19 start-page: 903 year: 2009 ident: 653_CR6 publication-title: Pharmacogent Genom doi: 10.1097/FPC.0b013e328331b554 – volume: 15 start-page: 8901 year: 2014 ident: 653_CR10 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2014.15.20.8901 – volume: 20 start-page: 382 year: 2016 ident: 653_CR20 publication-title: Gene Cell doi: 10.1111/gtc.12228 – volume: 324 start-page: 54 year: 2014 ident: 653_CR21 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2014.03.009 – volume: 10 start-page: 129 year: 2010 ident: 653_CR14 publication-title: BMC Cancer doi: 10.1186/1471-2407-10-129 – volume: 16 start-page: 3533 year: 2010 ident: 653_CR19 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-3169 – volume: 41 start-page: 991 year: 2009 ident: 653_CR24 publication-title: Nat Genet doi: 10.1038/ng.421 – volume: 9 start-page: 557 year: 2015 ident: 653_CR29 publication-title: Oncol Lett doi: 10.3892/ol.2014.2734 – volume: 14 start-page: 12346 year: 2013 ident: 653_CR3 publication-title: Int J Mol Sci doi: 10.3390/ijms140612346 – volume: 43 start-page: 632 year: 2011 ident: 653_CR17 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2011.01.002 – volume: 67 start-page: 1121 year: 2007 ident: 653_CR15 publication-title: Prostate doi: 10.1002/pros.20608 – volume: 168 start-page: 37 year: 2001 ident: 653_CR1 publication-title: Cancer Lett doi: 10.1016/S0304-3835(01)00497-9 – volume: 37 start-page: 449 year: 2016 ident: 653_CR27 publication-title: Carcinogenesis – volume: 31 start-page: 343 year: 2013 ident: 653_CR28 publication-title: Urol Oncol-Semin Ori doi: 10.1016/j.urolonc.2011.02.004 – volume: 61 start-page: 69 year: 2011 ident: 653_CR9 publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 65 start-page: 9495 year: 2005 ident: 653_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2086 – volume: 7 start-page: 1 year: 2014 ident: 653_CR8 publication-title: Mol Cytogenet doi: 10.1186/1755-8166-7-1 – volume: 7 start-page: 1065 year: 2016 ident: 653_CR2 publication-title: Genes doi: 10.3390/genes7020009 – volume: 109 start-page: 4974 year: 2012 ident: 653_CR5 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1202189109 – reference: 22416122 - Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4974-9 – reference: 16686711 - BJU Int. 2006 Jun;97(6):1202-7 – reference: 20083643 - Carcinogenesis. 2010 Apr;31(4):621-4 – reference: 23752272 - Int J Mol Sci. 2013 Jun 10;14(6):12346-66 – reference: 9465086 - Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1735-40 – reference: 25624885 - Oncol Lett. 2015 Feb;9(2):557-562 – reference: 25374226 - Asian Pac J Cancer Prev. 2014;15(20):8901-4 – reference: 20501618 - Clin Cancer Res. 2010 Jul 15;16(14):3533-8 – reference: 24657544 - Exp Cell Res. 2014 May 15;324(1):54-64 – reference: 11368875 - Cancer Lett. 2001 Jul 10;168(1):37-43 – reference: 22387998 - Nat Genet. 2012 Mar 04;44(4):430-4, S1-2 – reference: 17595048 - J Gene Med. 2007 Aug;9(8):715-26 – reference: 21429770 - Urol Oncol. 2013 Apr;31(3):343-51 – reference: 17492652 - Prostate. 2007 Jul 1;67(10):1121-31 – reference: 16230414 - Cancer Res. 2005 Oct 15;65(20):9495-500 – reference: 21296855 - CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 – reference: 19648920 - Nat Genet. 2009 Sep;41(9):991-5 – reference: 26785734 - Carcinogenesis. 2016 Mar;37(3):320-332 – reference: 21216304 - Int J Biochem Cell Biol. 2011 Apr;43(4):632-41 – reference: 20374648 - BMC Cancer. 2010 Apr 07;10:129 – reference: 25727947 - Genes Cells. 2015 May;20(5):382-91 – reference: 26891331 - Genes (Basel). 2016 Feb 16;7(2):null – reference: 19540661 - Cancer Lett. 2009 Dec 28;286(2):217-22 – reference: 26722457 - Int J Clin Exp Pathol. 2015 Oct 01;8(10 ):12678-87 – reference: 26550251 - Int J Clin Exp Med. 2015 Aug 15;8(8):13259-66 – reference: 19801959 - Pharmacogenet Genomics. 2009 Nov;19(11):903-6 |
SSID | ssj0000314641 |
Score | 2.1071224 |
Snippet | The aim of this study is to make a comparative evaluation on association of PSCArs2294008 C/T polymorphism with the risk of bladder cancer in Bai, Dai, and Han... |
SourceID | nrf proquest pubmed crossref springer |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 531 |
SubjectTerms | Alleles Animal Genetics and Genomics Biomedical and Life Sciences Bladder cancer Cancer Cell cycle Cell growth Cell migration Cell proliferation China genotype Genotype & phenotype Genotypes Health risk assessment Human Genetics Invasiveness Life Sciences Microbial Genetics and Genomics Minority & ethnic groups nationalities and ethnic groups neoplasm cells Overexpression Plant Genetics and Genomics Research Article Ribonucleic acid risk RNA tissues urinary bladder neoplasms 생물학 |
Title | PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism |
URI | https://link.springer.com/article/10.1007/s13258-018-0653-9 https://www.ncbi.nlm.nih.gov/pubmed/29892961 https://www.proquest.com/docview/2030254887 https://www.proquest.com/docview/2054926081 https://www.proquest.com/docview/2067273530 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002347372 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Genes & Genomics, 2018, 40(5), , pp.531-541 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoKyQuqOUZ-pBBnIBIjl-bHJc-WEAgJLpSOVl2Ypeo26RK0gNn_jgz2WRXFaUShyQHjx3HY4-_yYxnCHkdeF4ATnAxCxIUFJclcZqKIg4gC1khg0j6XARfvurZXH46U2fDOe529HYfTZK9pF4fdhNcoeMVXFqJONsgWwpVd5jEcz5d_VjBeOy6z1iZwFYbZ2qSjNbM21q5sR9tVE24DWr-ZSbtd5-TbfJwgI10uuTzDrnnq0fk_jKR5K_H5Pe374fTpuUcE5Cn9JRe1QtQ6mEMy_aSlhVCw9a3FNAeRWdyWgfqFih0Gpoj3xsgou9t-Y4e4c1WBZ3ZivruZ1XmANSxuE-13RdZaL9DNyPo0qXHs8PwmidkfnJ8ejiLh_QKcQ4opIstCEMfWMGC0jLPglPMqZAzqychVU7bJNWBhwQgW-GlZE57ZSVANml9qrQTT8lmVVf-OaGFA5ThPLOgP0leiEyIDJqaAJoIoHCpiLBxkE0-xB7HFBgLs46ajHwxwBeDfDFZRN6sqlwtA2_cRfwKOGcu8tJguGx8ntfmojGgFHw0gBh1xnVE9kbGmmGhtoaDkAMdGURtRF6uimGJod3EVr6-RhoMY6cBPN1FgyZtoQSLyLPlpFl1G4Pc80xD7bfjLFp34J_f9OK_qHfJA95PanTF3CObXXPt9wEude6AbE0__Ph8fNAvkz8S3Aee |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoEYIL4lkCBQziBERy7NgbH5dCtYW2QmJX6s2yExuibpMqSQ89948zk012hSiVOCQ5eOw4Hnv8TWY8Q8i7wPMCcIKLWUhBQXE6ibNMFHEAWciKNIikz0VwdKxmi_TriTwZznG3o7f7aJLsJfXmsJvgEh2v4FJSxHqL3AYskKEf14JP1z9WMB676jNWJrDVxlpOktGaeV0rf-xHW1UTroOaf5lJ-91n_wG5P8BGOl3x-SG55atH5M4qkeTlY3L1_cfetGk5xwTkGZ3T83oJSj2MYdme0bJCaNj6lgLao-hMTutA3RKFTkNz5HsDRPSTLT_Sz3izVUFntqK--1WVOQB1LO5TbfdFFtrv0M0IunTm8ewwvOYJWex_me_N4iG9QpwDCuliC8LQB1awIFWa6-AkczLkzKpJyKRTNslU4CEByFb4NGVOeWlTgGyp9ZlUTjwl21Vd-WeEFg5QhvPMgv6U8kJoITQ0NQE0EUDhkhFh4yCbfIg9jikwlmYTNRn5YoAvBvlidETer6ucrwJv3ET8FjhnTvPSYLhsfP6szWljQCk4MDBLlOYqIrsjY82wUFvDQciBjgyiNiJv1sWwxNBuYitfXyANhrFTAJ5uokGTtpCCRWRnNWnW3cYg91wrqP1hnEWbDvzzm57_F_Vrcnc2Pzo0hwfH316Qe7yf4OiWuUu2u-bCvwTo1LlX_VL5DWH_CP0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoEagXxLMNFDCIExDVsWNvclxaVlseVSW6Um-WndgQdZuskvTAmT_OTB67QpRKHJIcPHYcz3j8TcaeIeSN51kOOMGGzMdgoNg0CpNE5KEHXcjy2Iuoy0Xw9UTNF_Gnc3k-5Dltxt3uo0uyP9OAUZrK9mCV-4PNwTfBJW7CgktJEaZb5DZo4wjFesGn658sGJtdddkrI1h2w1ROotGzeV0rf6xNW2Xtr4Odf7lMu5Vodp_cGyAknfY8f0BuufIhudMnlfz5iPw6_XY4rRvOMRl5Qs_oqlqCgQ_jWTSXtCgRJjauoYD8KG4sp5WndokKqKYZykANRPSDKd7TI7yZMqdzU1LX_iiLDEA7Fndpt7siA-3jyIEc00uH54jhNY_JYvbx7HAeDqkWwgwQSRsaUIzOs5x5qeIs9VYyK33GjJr4RFplokR57iOAb7mLY2aVkyYG-BYbl0hlxROyXVal2yM0t4A4rGMGbKmY5yIVIoWmJoAsPBhfMiBsHGSdDXHIMR3GUm8iKCNfNPBFI190GpC36yqrPgjHTcSvgXP6Iis0hs7G5_dKX9QaDIRjDehRpVwFZH9krB4mbaM5KDywl0HtBuTVuhimG_pQTOmqK6TBkHYKgNRNNOjeFlKwgOz2QrPuNga856mC2u9GKdp04J_f9PS_qF-Su6dHM_3l-OTzM7LDO_nGHZr7ZLutr9xzQFGtfdHNlN-51w05 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PSCArs2294008+T+polymorphism+increases+the+risk+of+bladder+cancer+in+Bai%2C+Dai%2C+and+Han+ethnicity+in+China+and+a+potential+mechanism&rft.jtitle=Genes+%26+genomics&rft.au=Yang%2C+Junfeng&rft.au=Li%2C+Wei&rft.au=Zhang%2C+Zhuorui&rft.au=Shen%2C+Jie&rft.date=2018-05-01&rft.pub=Springer+Nature+B.V&rft.issn=1976-9571&rft.eissn=2092-9293&rft.volume=40&rft.issue=5&rft.spage=531&rft.epage=541&rft_id=info:doi/10.1007%2Fs13258-018-0653-9&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-9571&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-9571&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-9571&client=summon |